ABSTRACTSepsis is one of the major causes and predictors of death in patients with visceral leishmaniasis (VL). Globally, incidence rate of sepsis ranged from 56–91 cases per 100 000 people, with a mortality rate of 30%. Incidence of sepsis has been raised due to aging of the population and the higher incidence of immunosuppressive conditions such as HIV, VL and others. The prevalence of sepsis was reported from 4.2% to 32.3% and 14.1% in VL and VL-HIV coinfected patients, respectively. The mortality rate of VL patients with sepsis is greater than 50%. Factors associated with sepsis in VL patients are immune suppression, pancytopenia, HIV co-infection, age <1 year old and >40 years old, indwelling of central venous lines and hospitalization...
INTRODUCTION: The objective of the study is to identify the main risk factors for death by New World...
Introduction: Visceral Leishmaniasis is the most severe form of disease caused by the Leishmania don...
Objectives: Visceral leishmaniasis (VL) is re-emerging in endemic areas. The epidemiological, clinic...
Sepsis is one of the major causes and predictors of death in patients with visceral leishmaniasis (V...
ABSTRACTSepsis is one of the major causes and predictors of death in patients with visceral leishman...
Background and Objectives. Visceral leishmaniasis (VL) is one of the neglected diseases affecting th...
AbstractLeishmaniasis is a vector-born chronic infectious disease caused by a group of protozoan par...
Visceral leishmaniasis (VL) is a neglected tropical disease that affects the poorest communities and...
Twopatients admitted to the hospital because of severebacterial infection werediagnosed as having vi...
objectives To describe the clinical presentation of patients with visceral leishmaniasis (VL) with ...
BACKGROUND: Visceral leishmaniasis (VL) is an emerging condition affecting HIV-infected patients liv...
Objectives: Visceral leishmaniasis (VL) is re-emerging in endemic areas. The epidemiological, clinic...
Background: Bacterial infections are seen in patients with visceral leishmaniasis. This study was co...
Copyright © 2012 Geraldine Madalosso et al. This is an open access article distributed under the Cre...
Cases of visceral leishmaniasis (VL) in HIV-positive individuals have been reported from most areas ...
INTRODUCTION: The objective of the study is to identify the main risk factors for death by New World...
Introduction: Visceral Leishmaniasis is the most severe form of disease caused by the Leishmania don...
Objectives: Visceral leishmaniasis (VL) is re-emerging in endemic areas. The epidemiological, clinic...
Sepsis is one of the major causes and predictors of death in patients with visceral leishmaniasis (V...
ABSTRACTSepsis is one of the major causes and predictors of death in patients with visceral leishman...
Background and Objectives. Visceral leishmaniasis (VL) is one of the neglected diseases affecting th...
AbstractLeishmaniasis is a vector-born chronic infectious disease caused by a group of protozoan par...
Visceral leishmaniasis (VL) is a neglected tropical disease that affects the poorest communities and...
Twopatients admitted to the hospital because of severebacterial infection werediagnosed as having vi...
objectives To describe the clinical presentation of patients with visceral leishmaniasis (VL) with ...
BACKGROUND: Visceral leishmaniasis (VL) is an emerging condition affecting HIV-infected patients liv...
Objectives: Visceral leishmaniasis (VL) is re-emerging in endemic areas. The epidemiological, clinic...
Background: Bacterial infections are seen in patients with visceral leishmaniasis. This study was co...
Copyright © 2012 Geraldine Madalosso et al. This is an open access article distributed under the Cre...
Cases of visceral leishmaniasis (VL) in HIV-positive individuals have been reported from most areas ...
INTRODUCTION: The objective of the study is to identify the main risk factors for death by New World...
Introduction: Visceral Leishmaniasis is the most severe form of disease caused by the Leishmania don...
Objectives: Visceral leishmaniasis (VL) is re-emerging in endemic areas. The epidemiological, clinic...